Pharmaceutical companies commonly turn to contract development and manufacturing organizations (CDMOs) to assist with everything from early-stage product development to commercialization and large-scale manufacturing.

To find the best outsourcing partner, companies consider multiple factors, ranging from cultural fit to capacity, technical expertise, and more. A key question is whether to use one CDMO partner for end-to-end services throughout the product life cycle or to work with several outsourcing vendors at different stages of a project. A trusted CDMO like Cambrex that offers both end-to-end service and assistance with specific aspects of the drug development process may be a good alternative.

Experts from three pharma companies of different sizes shared their perspectives on CDMO partnerships in our recent virtual roundtable. Download the full summary below to access their insights!